Evolution of Treatment Products

Adapted from: Global NMO Training 2016 plenary presentation by Glenn Pierce Reviewed by: Glenn Pierce Edited by: Georghia Michael This second module in the Treatment Products eLearning Program explains the evolution of products for the treatment of bleeding disorders, from products derived from blood to artificially produced clotting factor concentrates (CFCs) with extended half-lives (EHL). […]

Factor Replacement Therapy Schematic

This illustrated schematic demonstrates the normal process of blood clotting, how it is diminished when a clotting factor is lacking, and how infusion of replacement therapy works to achieve normal levels of blood clotting. It also illustrates the clotting factor cascade and highlights the points in the cascade where each type of hemophilia treatment product […]

Factor Replacement Therapy Schematic

This illustrated schematic demonstrates the normal process of blood clotting, how it is diminished when a clotting factor is lacking, and how infusion of replacement therapy works to achieve normal levels of blood clotting. It also illustrates the clotting factor cascade and highlights the points in the cascade where each type of hemophilia treatment product […]

Factor Replacement Therapy Schematic

This illustrated schematic demonstrates the normal process of blood clotting, how it is diminished when a clotting factor is lacking, and how infusion of replacement therapy works to achieve normal levels of blood clotting. It also illustrates the clotting factor cascade and highlights the points in the cascade where each type of hemophilia treatment product […]

Schéma Illustré sur la Thérapie par Facteurs de Remplacement

Ce schéma illustré précise le processus normal de la coagulation sanguine, la baisse de coagulation en l’absence d’un facteur de coagulation et la façon dont la thérapie de remplacement par perfusion rétablit des valeurs de coagulation sanguine normales. Il illustre également la cascade des facteurs de coagulation et souligne les points dans la cascade où […]

Ilustración Esquemática del Funcionamiento de la Terapia de Reemplazo de Factor

Esta ilustración esquemática muestra el proceso normal de coagulación de la sangre, cómo resulta afectado cuando falta un factor de coagulación, y cómo funciona la infusión de terapia de reemplazo para lograr la coagulación sanguínea normal. También ilustra la cascada de los factores de coagulación y destaca los puntos en la cascada en los que […]

Factor Replacement Therapy Schematic

This illustrated schematic demonstrates the normal process of blood clotting, how it is diminished when a clotting factor is lacking, and how infusion of replacement therapy works to achieve normal levels of blood clotting. It also illustrates the clotting factor cascade and highlights the points in the cascade where each type of hemophilia treatment product […]

Agentes hemostáticos

[vc_row][vc_column][vc_column_text css=”.vc_custom_1469063757224{margin-bottom: 0px !important;border-bottom-width: 0px !important;padding-bottom: 10px !important;}”]This eLearning module presents Section 4 of the WFH Guidelines for the Management of Hemophilia: Hemostatic Agents. Detailed illustrations, interactive features, a glossary, supplementary resources and self-quizzes bring to life the WFH recommendations regarding FVIII and FIX clotting factor concentrates, fresh frozen plasma, cryoprecipitate, and other pharmacological options […]

Agents hémostatiques

[vc_row][vc_column][vc_column_text css=”.vc_custom_1469063807521{margin-bottom: 0px !important;border-bottom-width: 0px !important;padding-bottom: 10px !important;}”]This eLearning module presents Section 4 of the WFH Guidelines for the Management of Hemophilia: Hemostatic Agents. Detailed illustrations, interactive features, a glossary, supplementary resources and self-quizzes bring to life the WFH recommendations regarding FVIII and FIX clotting factor concentrates, fresh frozen plasma, cryoprecipitate, and other pharmacological options […]

Hemostatic Agents

[vc_row][vc_column][vc_column_text css=”.vc_custom_1469062763257{margin-bottom: 0px !important;border-bottom-width: 0px !important;padding-bottom: 10px !important;}”]This eLearning module presents Section 4 of the WFH Guidelines for the Management of Hemophilia: Hemostatic Agents. Detailed illustrations, interactive features, a glossary, supplementary resources and self-quizzes bring to life the WFH recommendations regarding FVIII and FIX clotting factor concentrates, fresh frozen plasma, cryoprecipitate, and other pharmacological options […]